Skip to main content
TipRanks
Go Ultimate75% OFF

Cooper Co (CP60) Stock Price & Analysis

0 Followers

CP60 Stock Chart & Stats

No data to display
Day’s Range
N/A
52-Week Range
N/A
Previous Close
N/A
Volume
N/A
Average Volume (3M)
N/A
Market Cap
CHF 10.00B
Enterprise Value
CHF 16.38B
Total Cash (Recent Filing)
CHF 154.70M
Total Debt (Recent Filing)
CHF 2.54B
Price to Earnings (P/E)
21.4
Beta
N/A
Next Earnings
Dec 03, 2026 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

Strong top-line expansion combined with a high gross margin indicates meaningful demand for the company’s medical device portfolio. If sustained, this supports reinvestment in innovation, commercial capabilities and capacity while providing a durable base for future earnings growth.

Fertility Market Position

Broad-based fertility demand and reported market share gains strengthen CooperSurgical’s position in an expanding care market. Clinic wins, genomics adoption and recurring service relationships can deepen customer ties and support more durable growth than a single product launch.

Conservative Leverage

Moderate and improving leverage gives Cooper flexibility to fund research, commercial investment and strategic initiatives without relying heavily on additional borrowing. The stronger equity base also improves resilience if operating conditions remain uneven over the coming quarters.

Bears Say

Weak Cash Conversion

The sharp TTM decline in operating and free cash flow weakens earnings quality and reduces internally generated funding for investment or shareholder returns. Cash conversion below net income also makes sustained performance more dependent on reversing the factors behind the deterioration.

Operating Margin Pressure

The large operating-margin contraction shows that revenue growth is not currently translating efficiently into operating profit. Additional commercial spending and foreign-exchange pressure may keep profitability below prior levels until execution investments generate sufficient productivity.

Leadership Transition

A chief executive departure and interim operating structure introduce execution and strategic continuity risk during a period that already includes margin pressure and commercial changes. The board search may ultimately strengthen leadership, but the transition can disrupt priorities over the next several quarters.

Cooper Co News

CP60 FAQ

What is Cooper Co’s market cap?
Cooper Co’s market cap is CHF10.00B.
When is Cooper Co’s upcoming earnings report date?
Cooper Co’s next earnings report is estimated for Dec 03, 2026 (not yet confirmed), which is in 17 days.
How were Cooper Co’s earnings last quarter?
Cooper Co released its earnings results on Sep 09, 2026. The company reported CHF0.965 earnings per share for the quarter, beating the consensus estimate of CHF0.943 by CHF0.022.
Is Cooper Co overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Cooper Co pay dividends?
Cooper Co does not currently pay dividends.
What is Cooper Co’s EPS estimate?
Cooper Co’s EPS estimate is 0.90.
What happened to Cooper Co’s price movement after its last earnings report?
Cooper Co reported an EPS of CHF0.965 in its last earnings report, beating expectations of CHF0.943. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of Cooper Co?
Hedge funds hold Cooper Co shares: the largest hedge-fund position in Cooper Co is 1,904,387,240 shares, and hedge funds increased their holdings by 2.5M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology